| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Nakamura T | |
| Iwamoto T | |||
| Toyama Y | |||
| Kuwahara M | |||
| Kamatani N | |||
| Momohara S | |||
| Tomatsu T | |||
| Ikari K | |||
| P2860 | cites work | Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease | Q22337234 |
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| A haplotype map of the human genome | Q24679827 | ||
| Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis | Q24812184 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease | Q28212615 | ||
| A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population | Q28255873 | ||
| Association between PADI4 and rheumatoid arthritis: a replication study | Q28275244 | ||
| Replication validity of genetic association studies | Q29615456 | ||
| Evolving concepts of rheumatoid arthritis | Q29618020 | ||
| Association study designs for complex diseases | Q34186026 | ||
| A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population | Q35555382 | ||
| New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. | Q37486377 | ||
| Large scale evidence and replication: insights from rheumatology and beyond | Q41790742 | ||
| Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. | Q44144728 | ||
| The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide | Q44791267 | ||
| PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population | Q46584884 | ||
| Guidelines for the management of rheumatoid arthritis: 2002 Update | Q56212157 | ||
| Genetic and genomic studies of PADI4 in rheumatoid arthritis | Q57667794 | ||
| P433 | issue | 7 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 804-807 | |
| P577 | publication date | 2006-01-31 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Association between PADI4 and rheumatoid arthritis: a meta-analysis | |
| P478 | volume | 45 |
| Q35993541 | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
| Q34043155 | A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis |
| Q41714407 | Aggregation of rare/low-frequency variants of the mitochondria respiratory chain-related proteins in rheumatoid arthritis patients. |
| Q45048663 | Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis |
| Q34436443 | Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study |
| Q38395166 | Association of IL-18 promoter gene polymorphisms with rheumatoid arthritis: a meta-analysis |
| Q33673310 | Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies |
| Q34159040 | Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. |
| Q36951043 | Citrullination by peptidylarginine deiminase in rheumatoid arthritis. |
| Q24316072 | Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation |
| Q52932746 | Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. |
| Q37454068 | Developments in the scientific understanding of rheumatoid arthritis |
| Q34530440 | Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening |
| Q39000109 | Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients |
| Q53317555 | Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. |
| Q42633268 | Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis |
| Q38957340 | Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy? |
| Q26783892 | Genetic studies of rheumatoid arthritis |
| Q37358260 | Genetics of rheumatoid arthritis: GWAS and beyond. |
| Q54330502 | Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis |
| Q49379545 | Hypoxia‑induced autophagy is inhibited by PADI4 knockdown, which promotes apoptosis of fibroblast‑like synoviocytes in rheumatoid arthritis |
| Q37716563 | Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis |
| Q64077474 | Increased peptidylarginine deiminases expression during the macrophage differentiation and participated inflammatory responses |
| Q37877927 | Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis |
| Q36917723 | Is anti-cyclic citrullinated Peptide antibody a good value biomarker for Alzheimer disease? |
| Q34857465 | Kinetics of human peptidylarginine deiminase 2 (hPAD2)--reduction of Ca2+ dependence by phospholipids and assessment of proposed inhibition by paclitaxel side chains |
| Q36984881 | Mechanisms of disease: genetics of rheumatoid arthritis--ethnic differences in disease-associated genes |
| Q34516914 | Meta-analysis of 125 rheumatoid arthritis-related single nucleotide polymorphisms studied in the past two decades |
| Q28211169 | Meta-analysis of association between the ASPN D-repeat and osteoarthritis |
| Q38747640 | PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis |
| Q34664095 | PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study |
| Q34081898 | PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population |
| Q37435917 | PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation |
| Q79693938 | PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis |
| Q46677052 | PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis |
| Q34027609 | Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study. |
| Q36441438 | Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies |
| Q48266844 | Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin |
| Q43076584 | Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors |
| Q38995539 | Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis |
| Q80219025 | Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies |
| Q26824670 | Rheumatoid arthritis susceptibility genes: An overview |
| Q37406509 | Role of peptidylarginine deiminase type 4 in gastric cancer |
| Q37401378 | Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis |
| Q39344907 | Targeting the programmed cell death-1 pathway in rheumatoid arthritis. |
| Q36736188 | The target tissue in autoimmunity--an influential niche |
| Q83188935 | [Possibilities and limitations of genomic analyses in rheumatoid arthritis] |
| Q27672732 | The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) i |
Search more.